Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis.
Srikanth N, Kumar A, Chandrasekhararao B, Singhal R, Yadav B, Khanduri S, Jameela S, Rai AK, Tripathi A, Rana R, Ahmad A, Sharma BS, Jaiswal A, Kotecha R; State Level Collaborators. Srikanth N, et al. Among authors: kotecha r. Front Public Health. 2022 Jul 6;10:904279. doi: 10.3389/fpubh.2022.904279. eCollection 2022. Front Public Health. 2022. PMID: 35900336 Free PMC article.
Benchmarking the Efficacy of Salvage Systemic Therapies for Recurrent Meningioma: A RANO Group Systematic Review and Meta-analysis to Guide Clinical Trial Design.
Kotecha R, Akdemir EY, Kutuk T, Ilgin C, Ahluwalia MS, Bi WL, Blakeley J, Dixit KS, Dunn IF, Galanis E, Galldiks N, Huang RY, Johnson DR, Kaley TJ, Kamson DO, Kurz SC, McDermott MW, Odia Y, Preusser M, Raizer J, Reardon DA, Rogers CL, Ruda R, Schiff D, Vogelbaum MA, Weller M, Wen PY, Mehta MP. Kotecha R, et al. Neuro Oncol. 2025 Jan 14:noaf009. doi: 10.1093/neuonc/noaf009. Online ahead of print. Neuro Oncol. 2025. PMID: 39807850
Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials.
Doshi SD, Knezevic A, Gonzalez C, Fischer P, Goodman R, Gornell S, Patel S, Puzio C, Ritea A, Lee CH, Evans L, Voss MH, Motzer RJ, Kotecha RR. Doshi SD, et al. Among authors: kotecha rr. Clin Genitourin Cancer. 2024 Nov 13;23(1):102268. doi: 10.1016/j.clgc.2024.102268. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39616970
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.
Khatri VM, Mestres-Villanueva MA, Yarlagadda S, Doniparthi A, Smith DB, Nakashima JY, Bryant JM, Zhao D, Upadhyay R, Mills MN, Oliver DE, Yu HM, Palmer JD, Williams NO, Mahtani RL, Ahluwalia MS, Soliman HH, Han HS, Soyano AE, Kim Y, Kotecha R, Beyer SJ, Ahmed KA. Khatri VM, et al. Among authors: kotecha r. NPJ Breast Cancer. 2024 Nov 21;10(1):100. doi: 10.1038/s41523-024-00711-w. NPJ Breast Cancer. 2024. PMID: 39572568 Free PMC article.
Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors.
Khaleel S, Perera M, Papa N, Kuo F, Golkaram M, Rappold P, Kotecha RR, Coleman J, Russo P, Motzer R, Reznik E, Hakimi AA. Khaleel S, et al. Among authors: kotecha rr. Urol Oncol. 2024 Nov 12:S1078-1439(24)00694-X. doi: 10.1016/j.urolonc.2024.10.013. Online ahead of print. Urol Oncol. 2024. PMID: 39537440
Initial feasibility cohort of temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade intracranial malignancies.
La Rosa A, Fellows Z, Wroe AJ, Coutinho L, Pons E, McAllister NC, Tolakanahalli R, Kutuk T, Hall MD, Press RH, McDermott MW, Odia Y, Ahluwalia MS, Mehta MP, Gutierrez AN, Kotecha R. La Rosa A, et al. Among authors: kotecha r. Sci Rep. 2024 Nov 4;14(1):26685. doi: 10.1038/s41598-024-78370-x. Sci Rep. 2024. PMID: 39496803 Free PMC article.
362 results